- Home
- HALO vs CIGI Comparison
HALO vs CIGI Comparison
Compare HALO & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- CIGI
- Stock Information
- Founded
- HALO 1998
- CIGI 1972
- Country
- HALO United States
- CIGI Canada
- Employees
- HALO N/A
- CIGI N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- CIGI
- Sector
- HALO Health Care
- CIGI
- Exchange
- HALO Nasdaq
- CIGI Nasdaq
- Market Cap
- HALO 7.6B
- CIGI 7.7B
- IPO Year
- HALO N/A
- CIGI N/A
- Fundamental
- Price
- HALO $66.96
- CIGI $157.69
- Analyst Decision
- HALO Buy
- CIGI Buy
- Analyst Count
- HALO 11
- CIGI 7
- Target Price
- HALO $73.09
- CIGI $174.33
- AVG Volume (30 Days)
- HALO 2.2M
- CIGI 107.4K
- Earning Date
- HALO 11-04-2025
- CIGI 11-04-2025
- Dividend Yield
- HALO N/A
- CIGI 0.19%
- EPS Growth
- HALO 68.93
- CIGI N/A
- EPS
- HALO 4.37
- CIGI 2.21
- Revenue
- HALO $1,178,672,000.00
- CIGI $5,169,495,000.00
- Revenue This Year
- HALO $32.57
- CIGI $16.18
- Revenue Next Year
- HALO $23.77
- CIGI $7.46
- P/E Ratio
- HALO $15.35
- CIGI $71.34
- Revenue Growth
- HALO 34.97
- CIGI 16.63
- 52 Week Low
- HALO $42.01
- CIGI $100.86
- 52 Week High
- HALO $79.50
- CIGI $170.65
- Technical
- Relative Strength Index (RSI)
- HALO 41.47
- CIGI 53.11
- Support Level
- HALO $63.80
- CIGI $149.80
- Resistance Level
- HALO $68.00
- CIGI $154.09
- Average True Range (ATR)
- HALO 2.30
- CIGI 3.10
- MACD
- HALO -0.48
- CIGI 0.39
- Stochastic Oscillator
- HALO 25.24
- CIGI 70.41
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.